Chris A. Rallis
Independent DirectorMr. Chris A. Rallis, J.D., had been an Independent Director at Tenax Therapeutics, Inc. since December 15, 2011 until June 11, 2021. He has been an Independent Director at Fennec Pharmaceuticals Inc. since August 25, 2011. Mr. Rallis joined the Fennec Pharmaceuticals Inc. on August 25, 2011. Mr. Rallis possesses particular healthcare industry knowledge and experience. Mr. Rallis has been an Executive-in-Residence at Pappas Ventures since January 2008. He served as President and Chief Operating Officer at Triangle Pharmaceuticals Inc. since January 2000. While at Triangle, he participated in 11 equity financings generating gross proceeds of approximately 500 million. He was also primarily responsible for all business development activities which included a worldwide alliance with Abbott Laboratories and the in-licensing of 10 compounds. He served as the President and Chief Executive Officer at ImmunoBiosciences, Inc., from April 2006 to June 2007. Prior to joining IBI, Mr. Rallis served as an executive in residence (part-time) for Pappas Ventures. He served as a Consultant for Duke University and Panacos Pharmaceuticals, Inc. Mr. Rallis served as an Executive Vice President of Business Development and General Counsel at Triangle Pharmaceuticals from August 1999 to February 2000 and as Vice President of Business Development, General Counsel and Secretary from November 1995 to July 1999. Before joining Triangle in 1995, he served in the following positions with Burroughs Wellcome Co: Vice President, Strategic Planning and Business Development; Director, Planning and Business Development; and Assistant General Counsel. During Mr. Rallis' tenure at Burroughs Wellcome, his department was responsible for finalizing licensing agreements with Emory University and Vertex Pharmaceuticals Incorporated and a consumer healthcare joint venture with Warner-Lambert Company. He has been a Director of Aeolus Pharmaceuticals Inc. (formerly, Aeolus Pharmaceuticals, Inc. (formerly known as Incara Pharmaceuticals Corporation).) since June 2004. He served as a Director of Triangle Pharmaceuticals Inc. since March 2000. Mr. Rallis Received his A.B. Degree in Economics from Harvard College and a J.D. from Duke University.
Positions
- Company NameFennec Pharmaceuticals Inc.Stock CodeFENCPositionIndependent DirectorColleagues
- JSJeffrey S. HackmanCEO & Director
- KIKhalid IslamIndependent Chairman of the Board
- RCRobert C. AndradeChief Financial Officer
- PSPierre S. SayadChief Medical Officer
- TETerry EvansChief Commercial Officer
- CCChristiana CioffiChief Strategy Officer
- MMMarco Maria BrugheraIndependent Director
- JAJodi Ann CookIndependent Director
